Yes, clinical trials involve risks, but these are minimized through strict regulations and oversight by entities like the FDA and an Institutional Review Board (IRB). The IRB reviews and monitors the trial to ensure your safety. While no trial is risk-free, the aim is to reduce risks to the lowest possible level. 

Any potential side effects are carefully tracked and analyzed to balance the benefits and risks of the treatment being studied. If any serious safety concerns arise, the trial may be paused or stopped.

Yes, your participation in a clinical trial includes financial compensation, which can range from $150 to $15,000, depending on the study’s duration and complexity. This compensation covers your time and travel expenses.

During your inpatient stay, Biotrial provides meals, snacks, and amenities such as TV and video games to ensure a comfortable experience.

Whether you can continue taking your regular medications during a clinical trial depends on the specific trial protocol.

All the Phase 1 studies we conduct at Biotrial require you to stop taking prescribed and over-the-counter medications to prevent interactions with the study drug. The recruitment team will inform you exactly what medications you can still use, such as painkillers.

The research team will provide guidance and closely monitor your health throughout the trial to ensure your safety.

Participation in a clinical trial requires some time spent at the research center for safety reasons and to ensure accurate results. However, Biotrial offers ambulatory trials, which minimize hospital stays and only require you to visit the center at scheduled times. 

These visits are crucial for completing necessary exams and monitoring your health. If your trial requires a stay of more than seven days, family visits are allowed to make your experience more comfortable.

For safety reasons, you cannot participate in multiple clinical trials simultaneously. After completing a trial, you must wait through an “exclusion period” (usually 30 days) before starting another.

This period allows your body to clear any drugs from the previous trial, ensuring your safety and the integrity of the study results. This waiting period is determined by health authorities and is known before the study begins.